Format

Send to

Choose Destination
Brain Nerve. 2018 Apr;70(4):427-438. doi: 10.11477/mf.1416201015.

[Dermatomyositis and Autoantibodies].

[Article in Japanese]

Author information

1
Department of Dermatology, Faculty of Medicine, University of Tsukuba.

Abstract

Recent studies have identified novel dermatomyositis-specific autoantibodies and revealed that disease-specific autoantibodies become positive at a high rate in this disease. Moreover, these autoantibodies have been demonstrated to show a strong correlation with distinct clinical manifestations and complications such as interstitial lung disease and malignancy. Thus, these autoantibodies are now recognized as useful tools to classify this varied disease into more homogeneous subsets. In this review, the clinical significance of five dermatomyositis-specific autoantibodies, anti-Mi-2, anti-MDA5, anti-TIF1, anti-NXP2, and anti-SAE, was described.

PMID:
29632290
DOI:
10.11477/mf.1416201015

Supplemental Content

Full text links

Icon for IGAKU-SHOIN Ltd.
Loading ...
Support Center